In the BioHarmony Drug Report Database

"Preview" Icon

Tiotropium

Spiriva, Spiriva Respimat (tiotropium) is a small molecule pharmaceutical. Tiotropium was first approved as Spiriva on 2004-01-30. It is used to treat chronic bronchitis and pulmonary emphysema in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M4. Spiriva handihaler’s patents are valid until 2030-10-16 (FDA).

 

Trade Name

 

Spiriva, Spiriva Respimat
 

Common Name

 

tiotropium
 

ChEMBL ID

 

CHEMBL1900528
 

Indication

 

chronic bronchitis, pulmonary emphysema
 

Drug Class

 

Quaternary ammonium derivatives; atropine derivatives

Image (chem structure or protein)

Tiotropium structure rendering